Bone Biologics annual free cash flow
2014
2015
Bone Biologics Free Cash Flow (FCF) History (BBLG)
Bone Biologics reported −$3.5M in free cash flow for fiscal 2015, a decrease of $778,768 from the previous fiscal year.
View full Bone Biologics company overviewBone Biologics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2015 | 2015-12-31 | −$3.5M | −$778,768 | — | — |
| 2014 | 2014-12-31 | −$2.8M | — | — | — |
Bone Biologics quarterly free cash flow
Q1.15
Q2.15
Q3.15
Q4.15
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2015 | 2015-12-31 | −$1.0M | — | — | — |
| Q3 2015 | 2015-09-30 | −$1.0M | — | — | — |
| Q2 2015 | 2015-06-30 | −$1.0M | — | — | — |
| Q1 2015 | 2015-03-31 | −$492,318 | — | — | — |
Bone Biologics free cash flow growth trends
Bone Biologics's latest reported quarter, Q4 2015, generated −$1.0M in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Bone Biologics filings at SEC.gov ↗